Financial Results, Monthly Sales Report, and Exclusive Holiday Offer - Research Report on Vitamin Shoppe, Rite Aid, Five Below,

    Financial Results, Monthly Sales Report, and Exclusive Holiday Offer -
   Research Report on Vitamin Shoppe, Rite Aid, Five Below, CST Brands, and
                                  PharMerica

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, November 8, 2013

NEW YORK, November 8, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Vitamin
Shoppe, Inc. (NYSE: VSI), Rite Aid Corporation (NYSE: RAD), Five Below, Inc.
(NASDAQ: FIVE), CST Brands, Inc. (NYSE: CST), and PharMerica Corporation
(NYSE: PMC). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

Vitamin Shoppe, Inc. Research Report

On November 5, 2013, Vitamin Shoppe, Inc. (Vitamin Shoppe) released its Q3 FY
2013 (period ended September 28, 2013) results with net sales of $272.5
million representing 14.0% YoY increase. The Company's net income declined by
0.1% YoY to $16.3 million and diluted EPS stood at $0.53 down 1.9% YoY during
the quarter. The Company stated that it opened 10 stores in the quarter and 33
new stores during 9M 2013. Tony Truesdale, CEO of Vitamin Shoppe, commented,
"We delivered our 32nd consecutive quarter of positive comparable retail store
sales growth and experienced improving traffic trends throughout the quarter.
We opened a new 311,000 square foot distribution center in Ashland, VA and
continued to successfully integrate Super Supplements, the largest acquisition
in the company's history." The Company stated that for full-Year 2013, it
expects low- to mid-single digit comparable store sales growth and plans to
open approximately 50 new stores and; and for full-year 2014, Vitamin Shoppe
anticipates mid single digit comparable store sales growth and intends to open
approximately 60 new stores. The Full Research Report on Vitamin Shoppe, Inc.
- including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

[http://www.AnalystsCrorner.com/r/full_research_report/5327_VSI]

--

Rite Aid Corporation Research Report

On October 31, 2013, Rite Aid Corporation (Rite Aid) announced sales results
for October 2013 (four-week period ended October 26, 2013). The Company
registered total drugstore sales of $2.0 billion, up 2.2% YoY and same store
sales increased 2.1% YoY. The Company reported that prescription sales
accounted for 69.1% of drugstore sales and third party prescription sales
represented 97.0% of pharmacy sales in October 2013. For the 34-week period
ended October 26, 2013, Rite Aid posted total drugstore sales of $16.4
billion, down 0.3% YoY and same store sales decreased 0.1% YoY. The Full
Research Report on Rite Aid Corporation - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

[http://www.AnalystsCorner.com/r/full_research_report/f64e_RAD]

--

Five Below, Inc. Research Report

On November 4, 2013, Five Below, Inc. (Five Below) unveiled its annual list of
the Hottest Teen Gifts for $5 (or Less!). Tom Vellios, CEO and Co-Founder of
Five Below, said, "At Five Below we pride ourselves on staying
up-to-the-minute on the latest shopping trends so that we can provide shoppers
with hot products at unbeatable $1 to $5 values. This holiday season we have a
broad, trend-right, and affordable selection of gifts for everyone on your
shopping list. With our list of the 2013 Hottest Teen Gifts for $5 (or Less!)
in hand, Five Below customers can be sure to find amazing gifts from
headphones to nail polish and more." The Company stated that 2013 Hottest Teen
Gifts for $5 (or Less!) list includes: Blast speaker, Mega candy banks,
Full-size rubber band loom, Character ornaments, DJ-style headphones, iPhone
and Samsung Galaxy two-ply tuff cases, Infinity scarves, Bare and smoky eye
palettes, Three-piece bath and body gift set, and Wham-O remote control
monster trucks and rad racers. The Full Research Report on Five Below, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

[http://www.AnalystsCorner.com/r/full_research_report/31b8_FIVE]

--

CST Brands, Inc. Research Report

On November 4, 2013, CST Brands, Inc. (CST Brands) released its Q3 2013
results. CST Brands registered operating revenues of $3.3 billion, compared to
$3.4 billion in Q3 2012. The Company posted net income of $41.0 million or
$0.55 per diluted share compared with $24.0 million or $0.31 in Q3 2012. Kim
Bowers, Chairman and CEO of CST Brands, stated, "We continue to make great
strides as a separate, publicly-traded company, working on key initiatives
such as establishing our culture, further developing our brand, and reducing
and eliminating the transition services being provided by our former parent
company. I am very proud of our hardworking team members across the company
that helped produce a very solid quarter." The Full Research Report on CST
Brands, Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

[http://www.AnalystsCorner.com/r/full_research_report/2b19_CST]

--

PharMerica Corporation Research Report

On November 5, 2013, PharMerica Corporation (PharMerica) reported its Q3 2013
results with revenues at $436.8 million compared to $442.0 million in Q3 2012.
The Company posted net loss of $6.2 million or $0.21 per diluted share,
compared to net income of $6.0 million or $0.20 per diluted share in Q3 2012.
Greg Weishar, PharMerica's CEO, said, "Sales productivity continues to improve
and we are poised to achieve the goal of organic growth in the near future.
Our superior cost containment programs, pharmacy services and industry-leading
generic dispensing rate of 83.3% position the Company to further improve
client retention and aggressively compete for market share in the long term
care market." For full-year 2013, the Company revised its revenue guidance to
be between $1.70 billion and $1.73 billion. The Full Research Report on
PharMerica Corporation - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

[http://www.AnalystsCorner.com/r/full_research_report/b04b_PMC]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we
    are only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Namrata Maheshwari,
CFA, has only reviewed the information provided by Equity News Network in this
article or report according to the Procedures outlined by Equity News Network.
Equity News Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles, documents or
reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.